MMP2 and neoplasm: In brief, MMP-2 and MMP-9 proteins are two crucial facilitators that are conducive to potentiating tumor metastatic and invasive potentials, these therapeutic candidate agents are expected to be used to the clinic CRC treatment and intervention by targeting the two crucial targets.